Africa Tech Insights
Insights into Africa's Tech Evolution
BillionToOne
Tunis, Tunisia
Editor’s Take
BillionToOne has developed a DNA molecular counter that increases the cell-free DNA diagnostics resolution by over 1,000 fold, which unlocks transformative improvements in prenatal screening and liquid biopsy for cancers. Unity Screen, BillionToOne's commercially available non-invasive prenatal test (NIPT), is the only NIPT that can assess fetal risk for both recessive conditions and aneuploidies from maternal blood. UNITY Screen continues to grow exponentially and is on its path to becoming the next standard-of-care, with an increasing number of publications showing its accuracy and advantages over other screening methods. We have also recently used our molecular counting technology to develop liquid biopsy tests, which have the potential to completely transform oncology care.
AI's Take
BillionToOne’s molecular counting technology enables unprecedented resolution for cell-free DNA diagnostics, which is crucial in both prenatal and cancer screenings. The UNITY Screen not only assesses fetal risk but also provides insights into both recessive conditions and aneuploidies, adding a layer of comprehensive assessment that is currently unparalleled in the market. The increasing publication of studies endorsing its accuracy suggests a strong scientific backing, which could expedite its acceptance as the new standard-of-care. Additionally, the application of this technology in oncology through liquid biopsy tests presents a substantial market opportunity, given the growing demand for less invasive cancer diagnostic methods. This dual focus on prenatal and oncology applications positions BillionToOne uniquely within the health sector.
AI Quick Insight on this news
BillionToOne has secured $120 million in Series B funding to advance its innovative DNA molecular counter technology, significantly enhancing cell-free DNA diagnostics. The company's flagship product, UNITY Screen, is revolutionizing prenatal screening and has the potential to transform cancer detection in liquid biopsies.
🔥 Key Takeaways
- BillionToOne's technology dramatically improves the resolution of DNA diagnostics, enhancing both prenatal screening and cancer detection.
- Strong scientific publications supporting UNITY Screen increase its credibility and potential adoption in clinical practice.
- The company’s dual application in prenatal and oncology markets creates a diversified growth opportunity amidst rising healthcare demands.
🎯 AI Confidence
🌍 Funding by Country
🏭 Funding by Sector
🔥 Related Startups
GoCab
Ride-hailing
💰 $45,000,000
GoCab, a ride-hailing platform operating in Ivory Coast, has raised $45 million through a... • Abidjan Côte D'Ivoire View Details →
Spiro
Electric Mobility
💰 $57,000,000
Spiro, a leading African electric mobility company, has secured over $50 million in debt f... • Nairobi Kenya View Details →
Breadfast
Online grocery
💰 $50,000,000
Egypt’s online grocery and quick-commerce platform Breadfast has secured $50 million in a... • Cairo Egypt View Details →Other Sectors
GoCab
Ride-hailing • Côte D'Ivoire💰 $45,000,000
GoCab, a ride-hailing platform operating in Ivory Coast, has raised $45 million through a...
View Details →
Spiro
Electric Mobility • Kenya💰 $57,000,000
Spiro, a leading African electric mobility company, has secured over $50 million in debt f...
View Details →
Breadfast
Online grocery • Egypt💰 $50,000,000
Egypt’s online grocery and quick-commerce platform Breadfast has secured $50 million in a...
View Details →
Terra Industries
Defense Tech • Nigeria💰 $34,000,000
Terra Industries, a fast-growing African defense technology startup, has raised an additio...
View Details →
Djamo
Fintech • Côte D'Ivoire💰 $17,000,000
Djamo is a challenger Bank for consumers in french speaking Africa where less than 25% of...
View Details →
Flutterwave
Fintech • Nigeria💰 $20,000,000
At Flutterwave, we are on a mission to build payments infrastructure to connect Africa to...
View Details →
